[go: up one dir, main page]

SG10201810362SA - Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition - Google Patents

Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition

Info

Publication number
SG10201810362SA
SG10201810362SA SG10201810362SA SG10201810362SA SG10201810362SA SG 10201810362S A SG10201810362S A SG 10201810362SA SG 10201810362S A SG10201810362S A SG 10201810362SA SG 10201810362S A SG10201810362S A SG 10201810362SA SG 10201810362S A SG10201810362S A SG 10201810362SA
Authority
SG
Singapore
Prior art keywords
agent
allergic
pharmaceutical composition
diarrhea
improving
Prior art date
Application number
SG10201810362SA
Inventor
Takeshi Takahashi
Hiroyuki Itou
Jun Kunisawa
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of SG10201810362SA publication Critical patent/SG10201810362SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Anti-Allergic Agent, Agent for Improving Allergic Diarrhea and Pharmaceutical Composition An anti-allergic agent comprising β-palmitic acid as an active ingredient can be applied as an anti-allergic agent which improves an allergic disease and which does not have side effects. [No Suitable Figure]
SG10201810362SA 2014-05-22 2015-05-22 Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition SG10201810362SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014106059 2014-05-22

Publications (1)

Publication Number Publication Date
SG10201810362SA true SG10201810362SA (en) 2018-12-28

Family

ID=54554148

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201609762TA SG11201609762TA (en) 2014-05-22 2015-05-22 Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition
SG10201810362SA SG10201810362SA (en) 2014-05-22 2015-05-22 Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201609762TA SG11201609762TA (en) 2014-05-22 2015-05-22 Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition

Country Status (5)

Country Link
JP (1) JPWO2015178492A1 (en)
CN (1) CN106413704A (en)
SG (2) SG11201609762TA (en)
TW (1) TWI669115B (en)
WO (1) WO2015178492A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112021408B (en) * 2020-09-30 2023-05-12 山东省大健康精准医疗产业技术研究院 Processing method for improving sensitization of milk powder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092959A (en) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd IgE antibody production inhibitor and antiallergic agent
JPH09121766A (en) * 1995-10-31 1997-05-13 Meiji Milk Prod Co Ltd Infant food with adjusted n-6 series / n-3 series fatty acid ratio
JP2008231094A (en) * 2007-02-20 2008-10-02 Univ Of Tokyo Antiallergic agent
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
EP2563167B9 (en) * 2010-04-26 2016-02-24 Enzymotec Ltd. Methods and lipid compositions for promoting development of gut flora

Also Published As

Publication number Publication date
WO2015178492A1 (en) 2015-11-26
JPWO2015178492A1 (en) 2017-04-20
SG11201609762TA (en) 2016-12-29
TW201625236A (en) 2016-07-16
TWI669115B (en) 2019-08-21
CN106413704A (en) 2017-02-15

Similar Documents

Publication Publication Date Title
IL267997A (en) Compositions, formulations and methods for treating ocular diseases
CA2956871C (en) Compounds active towards bromodomains
HK1217651A1 (en) Solid solution compositions and use in severe pain
HK1220980A1 (en) Methods and compositions for treatment of pompe disease
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
HK1217908A1 (en) Methods of treating cholangiocarcinoma
SG11201707087PA (en) Composition for diagnosing skin damage caused by fine dust, and composition comprising galangin as active ingredient
MX2021011906A (en) Delayed release compositions of linaclotide.
HK1218621A1 (en) Compositions and methods for treating chronic inflammation and inflammatory diseases
WO2014144295A8 (en) Ceftolozane antibiotic compositions
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
EP2995304A4 (en) Composition for preventing or treating symptoms of menopause comprising soybean extract comprising coumestrol as an active ingredient
MX2020002123A (en) Ribociclib salts and solid state forms thereof.
UA115357C2 (en) Pyridin-4-yl derivatives
EP3180993A4 (en) Composition for improving skin, containing pomegranate concentrate as active ingredient
WO2014121137A3 (en) Compositions and methods for the treatment of neurodegenerative and other diseases
EP3176163A4 (en) Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient
MY183068A (en) Pharmaceutical formulation comprising antibody
EP3138834A4 (en) Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
WO2014146111A3 (en) Analgesic compounds and methods of use
HK1223300A1 (en) Corticosteroid compositions